Details for New Drug Application (NDA): 208827
✉ Email this page to a colleague
The generic ingredient in HEPARIN SODIUM is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for 208827
Tradename: | HEPARIN SODIUM |
Applicant: | B Braun Medical Inc |
Ingredient: | heparin sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 208827
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 208827 | ANDA | B. Braun Medical Inc. | 0264-5705 | 0264-5705-10 | 10 BLISTER PACK in 1 CARTON (0264-5705-10) / 1 SYRINGE in 1 BLISTER PACK (0264-5705-05) / .5 mL in 1 SYRINGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 5,000 UNITS/0.5ML | ||||
Approval Date: | Nov 19, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription